Biotech company Amgen is investing $600 million in a new research center at its Thousand Oaks campus.
The new facility will create hundreds of jobs and feature advanced automation and digital capabilities, the company announced this week.
The investment will complement Amgen's existing research and development operations at its global headquarters in Ventura County, as well as eight other locations in the United States, Canada and Europe.
“This new center will provide our scientists with the tools and collaborative environment they need to shape the next era of scientific discovery and develop medicines that improve human health,” Amgen CEO Robert A. Bradway said in a press release.
Construction on this new facility is expected to begin soon and begin in the third quarter of this year.
This is one of Ventura County's largest single-project economic development investments and will replace an existing building in Thousand Oaks.
Founded in 1980, Amgen is recognized as a pioneer in the field of biotechnology. The company specializes in innovating and creating a variety of drugs to treat cancer, heart disease, osteoporosis, inflammatory diseases and other rare diseases.
The company employs 28,000 people worldwide, with 5,500 employees based in Ventura County. Last year, the company's revenue exceeded $33 billion.
Over the past several years, Amgen's research, development and manufacturing activities have expanded throughout the world. The company's largest production site is located in Puerto Rico.
The San Francisco area also has a new research center that opened in 2022. Last year, the company also announced a $1 billion manufacturing facility in North Carolina and a $950 million expansion of its Ohio facility.
